EyePoint (EYPT) Change in Accured Expenses (2010 - 2026)

EyePoint (EYPT) reported Change in Accured Expenses of $571000.0 for Q1 2026, down 88.52% on a YoY basis from $5.0 million in Q1 2025, and down 90.84% sequentially from $6.2 million in Q4 2025.

EyePoint (EYPT) Change in Accured Expenses (2010 - 2026) Analysis & Trends

EyePoint (EYPT) has 17 years of Change in Accured Expenses data on file, last reported at $571000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 88.52% year-over-year to $571000.0; the trailing twelve-month figure through Mar 2026 stood at $274000.0 (down 97.74% YoY), and the FY2025 full-year result was $4.7 million, down 18.39% from the prior year.
  • Change in Accured Expenses fell to $571000.0 in Q1 2026, from $6.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $8.1 million in Q4 2024 to a low of -$6.0 million in Q3 2024.
  • A 5-year average of $805647.1 and a median of $571000.0 in 2026 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses tumbled 263.13% in 2023 and jumped 1017.17% in 2024, its largest moves.
  • Tracing EYPT's Change in Accured Expenses over 5 years: stood at -$483000.0 in 2022, then soared by 250.72% to $728000.0 in 2023, then jumped by 1017.17% to $8.1 million in 2024, then retreated by 23.39% to $6.2 million in 2025, then sank by 90.84% to $571000.0 in 2026.
  • Business Quant data shows EYPT's Change in Accured Expenses at $571000.0 in Q1 2026, $6.2 million in Q4 2025, and -$3.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.13 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -16.82 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -16.74 Mn
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 571,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 571,000.00
Mar 31, 2026 571,000.00
Dec 31, 2025 6.23 Mn
Dec 31, 2025 6.23 Mn
Sep 30, 2025 -3.06 Mn
Sep 30, 2025 -3.06 Mn
Jun 30, 2025 -3.47 Mn
Jun 30, 2025 -3.47 Mn
Mar 31, 2025 4.97 Mn
Mar 31, 2025 4.97 Mn
Dec 31, 2024 8.13 Mn
Dec 31, 2024 8.13 Mn
Sep 30, 2024 -6.04 Mn
Sep 30, 2024 -6.04 Mn
Jun 30, 2024 5.07 Mn
Jun 30, 2024 5.07 Mn
Mar 31, 2024 -1.43 Mn
Mar 31, 2024 -1.43 Mn
Dec 31, 2023 728,000.00
Dec 31, 2023 728,000.00